glp-1 oral medication Why Weight-Loss Drugs Are Hard to Make into Pills WLP-1: Oral GLP-1 Support

In the DURATION-8 trial, patients treated with exenatide ER plus dapagliflozin achieved nearly double the weight reduction observed with each monotherapy, with numerically larger effects in individuals with higher baseline BMI

Of the study cohort, 92% had type 2 diabetes and 86% had obesity

Diabetologia 40 , 205211 (1997)

In this review, we discuss the cardiovascular effects of tirzepatide based on the available preclinical and clinical data

It is believed to arise secondary to impaired left ventricular relaxation during diastole, with obesity being a significant risk factor

Clinicians have reported using GLP-1RAs to short-circuit addictions to gambling and sex